New estimates of pharmaceutical research and development spending by US-based firms from 1984 to 2003

Joseph Golec and John A. Vernon
Additional contact information
Joseph Golec: Finance Department, School of Business, University of Connecticut, USA, Postal: Finance Department, School of Business, University of Connecticut, USA
John A. Vernon: Finance Department, School of Business, University of Connecticut, USA, Postal: Finance Department, School of Business, University of Connecticut, USA

Health Economics, 2007, vol. 28, issue 4-5, pages 481-483

Abstract: No Abstract

Date: 2007
View list of references

Downloads: (external link)
http://hdl.handle.net/10.1002/mde.1362 Link to full text; subscription required (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:wly:hlthec:v:28:y:2007:i:4-5:p:481-483

Access Statistics for this article

Health Economics is edited by Alan Maynard, John Hutton and Andrew Jones

More articles in Health Economics from John Wiley & Sons, Ltd.
Series data maintained by Christopher F. Baum ().